360 related articles for article (PubMed ID: 8591891)
21. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
Linz W; Wiemer G; Schölkens BA
J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
[TBL] [Abstract][Full Text] [Related]
22. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism.
Zhang X; Nasjletti A; Xu X; Hintze TH
J Cardiovasc Pharmacol; 1998 Apr; 31(4):623-9. PubMed ID: 9554814
[TBL] [Abstract][Full Text] [Related]
23. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.
Goto M; Liu Y; Yang XM; Ardell JL; Cohen MV; Downey JM
Circ Res; 1995 Sep; 77(3):611-21. PubMed ID: 7641331
[TBL] [Abstract][Full Text] [Related]
24. Do angiotensin converting enzyme inhibitors limit myocardial infarct size?
Miki T; Miura T; Shimamoto K; Urabe K; Sakamoto J; Iimura O
Clin Exp Pharmacol Physiol; 1993 Jun; 20(6):429-34. PubMed ID: 8339466
[TBL] [Abstract][Full Text] [Related]
25. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH
Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
[TBL] [Abstract][Full Text] [Related]
26. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
Wall TM; Linseman DA; Hartman JC
Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
[TBL] [Abstract][Full Text] [Related]
27. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
28. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
Sakamoto T; Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin?
Shimada Y; Avkiran M
J Cardiovasc Pharmacol; 1996 Mar; 27(3):428-38. PubMed ID: 8907806
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
31. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
32. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
33. Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Black SC; Driscoll EM; Lucchesi BR
Pharmacology; 1998 Jul; 57(1):35-46. PubMed ID: 9670211
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
35. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
Martorana PA; Schölkens BA
Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
[TBL] [Abstract][Full Text] [Related]
36. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Cachofeiro V; Sakakibara T; Nasjletti A
Hypertension; 1992 Feb; 19(2):138-45. PubMed ID: 1737647
[TBL] [Abstract][Full Text] [Related]
37. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels.
Node K; Kitakaze M; Kosaka H; Minamino T; Funaya H; Hori M
Circulation; 1997 Sep; 96(6):1953-63. PubMed ID: 9323086
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
40. Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels.
Zhang X; Xu X; Nasjletti A; Hintze TH
J Cardiovasc Pharmacol; 2000 Feb; 35(2):195-202. PubMed ID: 10672850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
